↓ Skip to main content

Cochrane Database of Systematic Reviews

Methotrexate for induction of remission in refractory Crohn's disease

Overview of attention for article published in Cochrane database of systematic reviews, August 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

policy
1 policy source
twitter
30 tweeters

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
214 Mendeley
Title
Methotrexate for induction of remission in refractory Crohn's disease
Published in
Cochrane database of systematic reviews, August 2014
DOI 10.1002/14651858.cd003459.pub4
Pubmed ID
Authors

John WD McDonald, Yongjun Wang, David J Tsoulis, John K MacDonald, Brian G Feagan

Abstract

Although corticosteroids are effective for induction of remission of Crohn's disease, many patients relapse when steroids are withdrawn or become steroid dependent. Furthermore, corticosteroids exhibit significant adverse effects. The success of methotrexate as a treatment for rheumatoid arthritis led to its evaluation in patients with refractory Crohn's disease. Methotrexate has been studied for induction of remission of refractory Crohn's disease and has become the principal alternative to azathioprine or 6-mercaptopurine therapy. This systematic review is an update of previously published Cochrane reviews.

Twitter Demographics

The data shown below were collected from the profiles of 30 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 214 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 <1%
Brazil 1 <1%
Italy 1 <1%
Colombia 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 207 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 33 15%
Student > Master 31 14%
Student > Ph. D. Student 30 14%
Student > Bachelor 25 12%
Other 18 8%
Other 43 20%
Unknown 34 16%
Readers by discipline Count As %
Medicine and Dentistry 104 49%
Pharmacology, Toxicology and Pharmaceutical Science 14 7%
Nursing and Health Professions 14 7%
Agricultural and Biological Sciences 9 4%
Psychology 5 2%
Other 26 12%
Unknown 42 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 November 2014.
All research outputs
#1,209,611
of 18,666,194 outputs
Outputs from Cochrane database of systematic reviews
#3,023
of 11,841 outputs
Outputs of similar age
#14,768
of 203,963 outputs
Outputs of similar age from Cochrane database of systematic reviews
#51
of 219 outputs
Altmetric has tracked 18,666,194 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,841 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.2. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,963 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 219 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.